Figure 4 from Blocking Tryptophan Catabolism Reduces Triple-Negative Breast Cancer Invasive Capacity by Li-Wei Kuo (18175968)

“…<p>AT-0174, a dual TDO2/IDO1 inhibitor, decreases TRP catabolism in anchorage-independent TNBC cells expressing TDO2 or IDO1 and reduces both formyl-KYN or KYN. …”

Histological evaluation of joints and osteoclastic activity after treatment with CoenzymeQ10 in MIA-induced OA. by Jennifer Lee (3439)

“…The joint lesions were graded on a scale of 0–13 using the modified Mankin scoring system. …”

Contents of PIO Program. by Jun-Seo Lim (21161776)

“…From October 2022 through December 2022, a total 66 participants were included. Results showed that the cognitive function of the experimental group increased by 3.9±3.66, from 18.1±4.54 before intervention to 21.9±5.17 after intervention; the control group increased by 0.1±4.13, from 18.2±4.91 before intervention to 18.2± 4.77 after intervention. …”

Demographic characteristics of participants. by Jun-Seo Lim (21161776)

“…From October 2022 through December 2022, a total 66 participants were included. Results showed that the cognitive function of the experimental group increased by 3.9±3.66, from 18.1±4.54 before intervention to 21.9±5.17 after intervention; the control group increased by 0.1±4.13, from 18.2±4.91 before intervention to 18.2± 4.77 after intervention. …”

Social robot PIO (version 3.5). by Jun-Seo Lim (21161776)

“…From October 2022 through December 2022, a total 66 participants were included. Results showed that the cognitive function of the experimental group increased by 3.9±3.66, from 18.1±4.54 before intervention to 21.9±5.17 after intervention; the control group increased by 0.1±4.13, from 18.2±4.91 before intervention to 18.2± 4.77 after intervention. …”

12 session programs of social robot PIO. by Jun-Seo Lim (21161776)

“…From October 2022 through December 2022, a total 66 participants were included. Results showed that the cognitive function of the experimental group increased by 3.9±3.66, from 18.1±4.54 before intervention to 21.9±5.17 after intervention; the control group increased by 0.1±4.13, from 18.2±4.91 before intervention to 18.2± 4.77 after intervention. …”

Functional annotation analysis of proteins with altered phosphorylation in rHla-treated 16HBE14o- and S9 cells. by Erik Richter (551398)

“…The dotted vertical line indicates the cut-off for significant enrichment (Benjamini-Hochberg corrected p-value ≤0.01). Numbers next to the horizontal bars provide the number of assigned proteins. …”

Novel paclitaxel formulations solubilized by parenteral nutrition nanoemulsions for application against glioma cell lines by Najlah, Mohammad

Get full text
Get full text
Get full text

Two-Dimensional Difference Gel Electrophoresis (DiGE) Analysis of Plasmas from Dengue Fever Patients by Lidiane M. Albuquerque (2333773)

“…The use of 2-D Fluorescence Difference Gel Electrophoresis to analyze plasmas depleted of six high-abundance proteins (albumin, IgG, antitrypsin, IgA, transferrin and haptoglobin) allowed for the detection of 73 differentially expressed protein spots (<i>n</i> = 13, <i>p</i> < 0.01), of which 37 could be identified by mass spectrometry. …”

Two-Dimensional Difference Gel Electrophoresis (DiGE) Analysis of Plasmas from Dengue Fever Patients by Lidiane M. Albuquerque (2333773)

“…The use of 2-D Fluorescence Difference Gel Electrophoresis to analyze plasmas depleted of six high-abundance proteins (albumin, IgG, antitrypsin, IgA, transferrin and haptoglobin) allowed for the detection of 73 differentially expressed protein spots (<i>n</i> = 13, <i>p</i> < 0.01), of which 37 could be identified by mass spectrometry. …”

Two-Dimensional Difference Gel Electrophoresis (DiGE) Analysis of Plasmas from Dengue Fever Patients by Lidiane M. Albuquerque (2333773)

“…The use of 2-D Fluorescence Difference Gel Electrophoresis to analyze plasmas depleted of six high-abundance proteins (albumin, IgG, antitrypsin, IgA, transferrin and haptoglobin) allowed for the detection of 73 differentially expressed protein spots (<i>n</i> = 13, <i>p</i> < 0.01), of which 37 could be identified by mass spectrometry. …”

<i>MYCN</i> promoted cell cycle progression and increased the ratios of myeloid cells and its precursors. by Li-Jing Shen (390172)

“…All the detections repeated 3 times and analyzed in the two histograms (F, I) both indicated that myeloid cells and precursors were increased in Tg fish, correspondingly erythrocytes dramatically decreased, meeting the results of peripheral blood smear. **, P<0.01</p>…”

Prevention of skin flap necrosis in mice by EMSCs injection. by Chun-Chun Cheng (324809)

“…(E) Immunostaining of von Willebrand factor (vWF) of skin flap, and (F) its quantification showed significantly more vWF expressed cells (arrowhead) in the EMSCs injected group than the control group. **represents <i>P</i><0.01. Scale bars represent 100 µm. Data are presented as mean ± s.d. and analyzed with Student's <i>t</i>-test. …”

Image_1_Intra-Arterial Thrombolysis Vs. Mechanical Thrombectomy in Acute Minor Ischemic Stroke Due to Large Vessel Occlusion.TIF by Dapeng Sun (319496)

“…As compared to MT group, patients in the IAT alone group were associated with a higher chance of 90-day mRS 0-2 [93.7% vs. 71.9%, odds ratio (OR) = 4.75, 95% confidence interval (CI): 1.20–18.80, P = 0.027], a high chance of 90-day mRS 0-3 (96.8% vs. 86.7%, OR = 11.35, 95% CI: 1.93–66.86, P = 0.007), a shorter median time from puncture to recanalization (PTR) (60 min vs. 100 min, β = −63.70, 95% CI: −81.79– −45.61, P < 0.001), a lower chance of any intracranial hemorrhage (ICH) within 48 h (3.2% vs. 19.3%, OR = 0.15, 95% CI: 0.03–0.79, P = 0.025), and a lower chance of mortablity within 90 days (1.6% vs. 9.2%, OR = 0.05, 95% CI: 0.01–0.57, P = 0.016). …”

Image_2_Intra-Arterial Thrombolysis Vs. Mechanical Thrombectomy in Acute Minor Ischemic Stroke Due to Large Vessel Occlusion.TIF by Dapeng Sun (319496)

“…As compared to MT group, patients in the IAT alone group were associated with a higher chance of 90-day mRS 0-2 [93.7% vs. 71.9%, odds ratio (OR) = 4.75, 95% confidence interval (CI): 1.20–18.80, P = 0.027], a high chance of 90-day mRS 0-3 (96.8% vs. 86.7%, OR = 11.35, 95% CI: 1.93–66.86, P = 0.007), a shorter median time from puncture to recanalization (PTR) (60 min vs. 100 min, β = −63.70, 95% CI: −81.79– −45.61, P < 0.001), a lower chance of any intracranial hemorrhage (ICH) within 48 h (3.2% vs. 19.3%, OR = 0.15, 95% CI: 0.03–0.79, P = 0.025), and a lower chance of mortablity within 90 days (1.6% vs. 9.2%, OR = 0.05, 95% CI: 0.01–0.57, P = 0.016). …”

Investigation of the rheological properties of nanosilica-reinforced polyacrylamide/polyethyleneimine gels for wellbore strengthening at high reservoir temperatures by Shamlooh M.

“…The objective of this work is to investigate the effect of nanosilica sizes (8, 20, 50, and 85 nm) and concentrations (0.1–2 wt %) on the stability and viscoelastic behavior of polyacrylamide (PAM) cross-linked with polyethyleneimine (PEI) at 130 °C. …”
Get full text
Get full text

Enhanced bioelectrochemical treatment of petroleum refinery wastewater with Labaneh whey as co-substrate by Mohanakrishna, Gunda

Get full text
Get full text
Get full text

Image_1_Alterations of NURR1 and Cytokines in the Peripheral Blood Mononuclear Cells: Combined Biomarkers for Parkinson’s Disease.TIF by Tianbai Li (6020375)

“…Our data showed that NURR1 gene expression was significantly decreased in the PBMCs of PD as compared with that of HC and NDC (p < 0.01). …”

Image_2_Alterations of NURR1 and Cytokines in the Peripheral Blood Mononuclear Cells: Combined Biomarkers for Parkinson’s Disease.TIF by Tianbai Li (6020375)

“…Our data showed that NURR1 gene expression was significantly decreased in the PBMCs of PD as compared with that of HC and NDC (p < 0.01). …”

Table_1_Alterations of NURR1 and Cytokines in the Peripheral Blood Mononuclear Cells: Combined Biomarkers for Parkinson’s Disease.DOCX by Tianbai Li (6020375)

“…Our data showed that NURR1 gene expression was significantly decreased in the PBMCs of PD as compared with that of HC and NDC (p < 0.01). …”